Shizuo Mukai, M.D.
Pediatric Retina Service
Massachusetts Eye and Ear
243 Charles Street
Boston, MA 02114
|Office Hours:||Monday through Friday, 9:00am - 5:00pm|
|Medical School||Brown Medical School|
|Residency||Ophthalmology, Harvard Medical School Department of Ophthalmology Residency Training Program|
|Fellowship||Vitreoretinal Surgery, Mass. Eye and Ear|
|Teaching Affiliation||Associate Professor in Ophthalmology, Harvard Medical School|
Medical and surgical management of vitreoretinal diseases, pediatric retina, retinal tumors, genetics of retinal diseases
Retinal stem cells, molecular genetics of retinal diseases, new treatment approaches to retinoblastoma, retinal photography
Daniels AB, Jakobiec FA, Westerfeld CB, Hagiwara A, Michaud N, Mukai S. Idiopathic subfoveal choroidal neovascular membrane in a 21-month-old child: ultrastructural features and implication for membranogenesis. J AAPOS. 2010 Jun; 14(3): 244-50.
Vavvas D, Kim I, Lane AM, Chaglassian A, Mukai S, Gragoudas E. Posterior uveal melanoma in young patients treated with proton beam therapy. Retina. 2010 Sep; 30(8): 1267-71.
Lei H, Rhéaume MA, Velez G, Mukai S, Kazlauskas A. Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells. Invest Ophthalmol Vis Sci. 2011 Aug; 52(9): 5016-21.
Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM, MacPherson D. miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev. 2011 Aug 15; 25(16): 1734-45.
Pennock S, Rheaume MA, Mukai S, Kazlauskas A. A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy. Am J Pathol. 2011 Dec; 179(6): 2931-40.